Texas Instruments Inc (EXAS:NASDAQ)
$104.91 0.99 (0.9527%)
Analysed Texas Instruments Inc (EXAS:NASDAQ) News Sources
Abbott Laboratories (ABT) Announces Completion of Acquisition of Exact Sciences
26-03-2026
yahoo.com
Abbott closes $23 billion deal to buy Madison-based Exact Sciences
24-03-2026
jsonline.com
Abbott completes acquisition of Exact Sciences
23-03-2026
yahoo.com
Clearwater Analytics Stock Lands $37 Million Investment Amid 77% ARR Growth Surge and Pending Buyout
22-03-2026
fool.com
This $19.8 Million Bet on Commvault Comes Amid a 51% Drop. Here’s What Investors Should Know
22-03-2026
fool.com
How Walgreens’ Pharmacy-Led Cologuard Expansion At Exact Sciences (EXAS) Has Changed Its Investment Story
22-03-2026
yahoo.com
Abbott acquisition of Exact Sciences set to close on March 23, 2026
20-03-2026
yahoo.com
Abbott to close $21B Exact Sciences acquisition Monday
20-03-2026
medtechdive.com
Exact Sciences to Present New Molecular Residual Disease and Multi-Cancer Early Detection Data at AACR 2026
17-03-2026
yahoo.com
1 Mid-Cap Stock to Consider Right Now and 2 Facing Headwinds
17-03-2026
yahoo.com
What is the current price of Texas Instruments Inc (EXAS:NASDAQ)?
The current price of Texas Instruments Inc (EXAS:NASDAQ) is $104.91.
Texas Instruments Inc (EXAS:NASDAQ) absolute price change since previous trading day?
The absolute price change of Texas Instruments Inc (EXAS:NASDAQ) since the previous trading day is $0.99.
Texas Instruments Inc (EXAS:NASDAQ) percentage price change since previous trading day?
The percentage price change of Texas Instruments Inc (EXAS:NASDAQ) since the previous trading day is 0.9527%.
What is the most recent average sentiment score for Texas Instruments Inc (EXAS:NASDAQ)?
The most recent average sentiment score for Texas Instruments Inc (EXAS:NASDAQ) is 89 out of 100.
What is the most recent average sentiment for Texas Instruments Inc (EXAS:NASDAQ)?
The most recent sentiment for Texas Instruments Inc (EXAS:NASDAQ) is .
SEC-8K** Filing Available For Texas Instruments Inc (EXAS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.